Guide · Hemp · Product Classification

Total THC vs. Delta-9 After the 2026 Federal and State Changes

The controlling THC metric now depends on the jurisdiction, product category, and effective date. Product teams should classify each SKU using the exact federal, Illinois, and Missouri definitions rather than a single delta-9 number.

By Lincoln Square Law · 8-minute read

For a hemp or cannabis operator, “delta-9 THC” and “total THC” are not interchangeable labels. They answer different legal questions, and in 2026 the distinction became a transition-management issue rather than a chemistry footnote. The federal hemp definition is moving away from the 2018 framework that focused on delta-9 THC concentration alone, Illinois has enacted a state hemp framework that expressly counts tetrahydrocannabinolic acid (THCA) in total THC, and Missouri has enacted its own intoxicating-cannabinoid statute. A product team that uses one number for every jurisdiction can misclassify a SKU even when the laboratory report itself is accurate.

Start with the statutory question, not the marketing name

The first question is not whether a product is called “hemp,” “THCA flower,” “delta-8,” “full spectrum,” or “non-intoxicating.” The first question is which legal definition applies to the product, on what date, and in which jurisdiction.

Under the 2018 federal framework, hemp was defined around a delta-9 THC concentration limit on a dry-weight basis.

Public Law 119-37 §781 amended that structure. Public Law 119-103 §2019 then limited the application of most of those amendments through December 11, 2026. As of this writing, operators therefore need a date-specific federal analysis instead of a single before-and-after slogan.

The compliance file should identify the product form, all cannabinoids present, whether any cannabinoid was synthesized or manufactured outside the plant, the relevant concentrations and per-container quantities, the laboratory method, the date the test was performed, and the legal rule being applied. The conclusion should be reproducible by someone who did not participate in product development.

Delta-9 measures one cannabinoid, and total THC captures more of the conversion risk

Delta-9 THC is one cannabinoid. THCA is its acidic precursor. Heat can convert THCA to delta-9 THC through decarboxylation. A rule that looks only to delta-9 concentration can therefore produce a different legal classification from a rule that expressly includes THCA or otherwise measures total tetrahydrocannabinols. That difference is particularly important for flower and other products whose effect or composition changes when heated.

Illinois Public Act 104-0463 makes the state approach explicit. The Illinois Hemp Act defines hemp using a total tetrahydrocannabinol concentration that includes THCA. It also defines a qualifying final consumer hemp cannabinoid product, among other conditions, by reference to a per-container ceiling of 0.4 milligrams of total tetrahydrocannabinols, including THCA and other cannabinoids that the statute treats similarly. The relevant Illinois question is therefore not merely whether a certificate of analysis lists delta-9 below 0.3 percent.

Concentration and per-container milligrams solve different problems

A percentage concentration limit and a milligram-per-container limit are mathematically and legally different controls.

A dry-weight percentage asks how much of the material is THC relative to the product’s dry weight. A per-container milligram rule asks how much specified cannabinoid content is present in the package sold to the consumer. A large or heavy product can satisfy one test while failing another. Product review should therefore calculate each metric the governing law requires rather than converting one into a substitute for the other.

For every SKU, maintain a worksheet that shows net weight, cannabinoid concentration, calculated milligrams, container count, serving count, and the source laboratory result. If the statute uses a definition such as “container,” use the statutory definition, not the packaging team’s commercial terminology. A multipack, outer carton, inner bottle, pouch, or cartridge can create classification questions that should be resolved before labels are printed.

Federal timing still matters after the 2026 extension

Public Law 119-103 §2019 provides that until December 11, 2026, the amendments made by §781 of Public Law 119-37 apply only to two specified product subclauses in amended 7 U.S.C. §1639o. That means the transition cannot accurately be described as “everything changed November 12” or “nothing changes until December 11.” The correct answer depends on which amended subclause describes the product. A company selling multiple cannabinoid categories should classify them separately.

Operationally, that calls for a transition table. Put every SKU in a row. Add columns for product form, cannabinoid source, naturally occurring or synthesized status, delta-9 concentration, total THC/THCA values, per-container cannabinoid amounts, federal treatment before November 12, treatment during the limited period through December 11, and treatment beginning after that period unless Congress changes the law again. Assign a responsible employee to verify the legal status before each transition date.

Illinois is not waiting for a federal label to do the state’s work

Illinois Public Act 104-0463 became law June 12, 2026. It creates the Illinois Hemp Act and makes related amendments across Illinois cannabis and controlled-substance law. Some provisions operate on their own effective dates, and the former Industrial Hemp Act is scheduled for repeal on November 12, 2026. Operators selling or distributing hemp-derived cannabinoid products in Illinois should therefore map Illinois requirements independently from the federal hemp definition.

The practical consequence is that a product’s federal status is only one line in the analysis. The Illinois file should also address whether the product fits the state definition of hemp, whether it qualifies as a final consumer hemp cannabinoid product, age-verification requirements where applicable, packaging or labeling obligations, and whether the product instead falls within Illinois cannabis controls. A federal “hemp” conclusion does not by itself establish that a particular retail sale is authorized under Illinois law.

Missouri adds another classification layer

Missouri’s RSMo §195.900, effective November 12, 2026, is expressly titled the Intoxicating Cannabinoid Control Act.

It uses a total-THC hemp definition that includes THCA and identifies categories of hemp-derived cannabinoid products that are brought within the marijuana regulatory structure. The statute also coordinates part of its effective operation with federal hemp restrictions if Congress changes federal timing. That makes Missouri another jurisdiction where a federal delta-9-only answer is insufficient.

A multi-state operator should resist building one national SKU-status field called “hemp yes/no.” Use jurisdiction-specific classifications and an effective-date field. A product may be lawfully produced in one state, restricted in another, and subject to a changed federal definition on a future date. The compliance system needs to preserve those distinctions.

Read the certificate of analysis as evidence, not as a legal conclusion

A COA reports test results. It does not decide which statute applies, whether the sampling method satisfies a particular program, whether a cannabinoid was synthesized outside the plant, whether the correct lot was tested, or whether the product’s package size changes the legal result. Counsel and compliance personnel should connect the COA to the batch record, formulation record, production method, packaging specification, and governing definition.

When the law uses THCA or total-THC concepts, confirm that the laboratory report contains the data needed to apply them. When the law distinguishes naturally produced cannabinoids from synthesized or manufactured cannabinoids, obtain formulation and supply-chain records that answer that question. If a supplier will provide only a marketing assurance that an ingredient is “hemp compliant,” treat that as incomplete diligence.

Build change control around formulas and labels

A product can move out of compliance without anyone changing its brand name. A supplier may change an extract. A manufacturer may alter serving size. A packaging team may increase container volume. A laboratory may report a different cannabinoid profile. A new statute may change which metric controls. Product change control should therefore require legal/compliance review when formula, source material, cannabinoid process, package size, label claims, or governing law changes.

The review record should state what changed, what legal tests were rerun, who approved the change, and which labels or inventory lots are affected. That makes a later regulator inquiry manageable and prevents the company from relying on a stale legal analysis after the product has materially changed.

The decision is a matrix, not a single THC number

For 2026 planning, the defensible workflow is: identify the jurisdiction and effective date, identify the product category and cannabinoid production method, capture delta-9, THCA, total-THC and per-container data required by that law, apply the relevant federal and state definitions separately, then document the sales channels the classification permits.

The resulting file should be understandable to product, sales, compliance, finance, and outside laboratories.

That discipline is more useful than arguing over whether “delta-9” or “total THC” is the better scientific measure. The operator’s job is to apply the measure the governing law actually uses, on the date it applies, and to preserve the evidence supporting the classification.